473 related articles for article (PubMed ID: 33205006)
41. The Transmembrane Domains of β and IX Subunits Mediate the Localization of the Platelet Glycoprotein Ib-IX Complex to the Glycosphingolipid-enriched Membrane Domain.
Xu G; Shang D; Zhang Z; Shaw TS; Ran Y; López JA; Peng Y
J Biol Chem; 2015 Sep; 290(36):22155-62. PubMed ID: 26203189
[TBL] [Abstract][Full Text] [Related]
42. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.
Veldman RJ; Mita A; Cuvillier O; Garcia V; Klappe K; Medin JA; Campbell JD; Carpentier S; Kok JW; Levade T
FASEB J; 2003 Jun; 17(9):1144-6. PubMed ID: 12692077
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
44. Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency.
Aoki K; Heaps AD; Strauss KA; Tiemeyer M
Clin Mass Spectrom; 2019 Nov; 14 Pt B():106-114. PubMed ID: 34917767
[TBL] [Abstract][Full Text] [Related]
45. Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities.
Annor GK; Elshabassy N; Lundine D; Conde DG; Xiao G; Ellison V; Bargonetti J
Front Cell Dev Biol; 2021; 9():772315. PubMed ID: 34881245
[TBL] [Abstract][Full Text] [Related]
46. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
47. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
48. Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
Basak D; Punganuru SR; Srivenugopal KS
Int J Oncol; 2016 Apr; 48(4):1426-36. PubMed ID: 26848023
[TBL] [Abstract][Full Text] [Related]
49. Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma.
Byrne FL; Olzomer EM; Lolies N; Hoehn KL; Wegner MS
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562868
[TBL] [Abstract][Full Text] [Related]
50. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
Wu X; Lu Y; Qin X
J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
[TBL] [Abstract][Full Text] [Related]
51. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
[TBL] [Abstract][Full Text] [Related]
52. Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.
Akiyama H; Miller C; Patel HV; Hatch SC; Archer J; Ramirez NG; Gummuluru S
J Virol; 2014 Aug; 88(16):8813-25. PubMed ID: 24872578
[TBL] [Abstract][Full Text] [Related]
53. Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53.
Zhang Y; Guo T; Li S; Ren Z; Gao S; Lu H; Ma X; Liu D; Liu Y; Kong D; Qiu Y
Discov Oncol; 2023 May; 14(1):84. PubMed ID: 37256374
[TBL] [Abstract][Full Text] [Related]
54. p53-R273H upregulates neuropilin-2 to promote cell mobility and tumor metastasis.
Lv T; Wu X; Sun L; Hu Q; Wan Y; Wang L; Zhao Z; Tu X; Xiao ZJ
Cell Death Dis; 2017 Aug; 8(8):e2995. PubMed ID: 28796261
[TBL] [Abstract][Full Text] [Related]
55. Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells.
Van Slambrouck S; Steelant WF
Biochem J; 2007 Feb; 401(3):689-99. PubMed ID: 16995838
[TBL] [Abstract][Full Text] [Related]
56. Traveling for the glycosphingolipid path.
Hakomori S
Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
[TBL] [Abstract][Full Text] [Related]
57. p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells.
Dong P; Tada M; Hamada J; Nakamura A; Moriuchi T; Sakuragi N
Clin Exp Metastasis; 2007; 24(6):471-83. PubMed ID: 17636407
[TBL] [Abstract][Full Text] [Related]
58. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
[TBL] [Abstract][Full Text] [Related]
59. Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU
Gao X; Zheng X; Zhang Y; Dong L; Sun L; Zhao N; Ding C; Ma Z; Wang Y
Front Cell Dev Biol; 2021; 9():788331. PubMed ID: 35071232
[No Abstract] [Full Text] [Related]
60. Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3.
Gehrmann M; Liebisch G; Schmitz G; Anderson R; Steinem C; De Maio A; Pockley G; Multhoff G
PLoS One; 2008 Apr; 3(4):e1925. PubMed ID: 18382692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
